TGF-β functions as a tumour suppressor by inhibiting the growth of untransformed epithelial, endothelial and lymphoid cells [4,5,6] and resistance to TGF-β is regarded as one of the crucial steps in malignant progression [2,7]. This evidence concerns the gene TGFB1 and neoplasm.